| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of knowledge
|
Levin, Adeera
|
|
2002
|
|
S80 |
p. S35-S38
4 p.
|
artikel
|
| 2 |
An update on the referral pattern of patients with end-stage renal disease
|
Lameire, Norbert
|
|
2002
|
|
S80 |
p. S27-S34
8 p.
|
artikel
|
| 3 |
Cardiovascular disease after renal transplantation
|
Dimény, Emöke M.
|
|
2002
|
|
S80 |
p. S78-S84
7 p.
|
artikel
|
| 4 |
Cell apoptosis and hemodialysis-induced inflammation
|
Carracedo, Julia
|
|
2002
|
|
S80 |
p. S89-S93
5 p.
|
artikel
|
| 5 |
Chronic inflammation and clinical outcome in adult hemodialysis patients
|
Lowrie, Edmund G.
|
|
2002
|
|
S80 |
p. S94-S98
5 p.
|
artikel
|
| 6 |
Control of uremic bone disease: Role of vitamin D analogs
|
Slatopolsky, Eduardo
|
|
2002
|
|
S80 |
p. S143-S148
6 p.
|
artikel
|
| 7 |
Darbepoetin alfa: A new therapeutic agent for renal anemia
|
Macdougall, Iain C.
|
|
2002
|
|
S80 |
p. S55-S61
7 p.
|
artikel
|
| 8 |
Fernando Valderrábano
|
Guajardo, Damaso Sanz
|
|
2002
|
|
S80 |
p. S1-S2
2 p.
|
artikel
|
| 9 |
Hemodialyzer: From macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers
|
Ronco, Claudio
|
|
2002
|
|
S80 |
p. S126-S142
17 p.
|
artikel
|
| 10 |
How should the immunosuppressive regimen be managed in patients with established chronic allograft failure?
|
Danovitch, Gabriel M.
|
|
2002
|
|
S80 |
p. S68-S72
5 p.
|
artikel
|
| 11 |
Hyperlipidemia: A risk factor for chronic allograft dysfunction
|
Castelló, Isabel Beneyto
|
|
2002
|
|
S80 |
p. S73-S77
5 p.
|
artikel
|
| 12 |
Inflammation and cardiovascular risk in dialysis patients
|
Wanner, Christoph
|
|
2002
|
|
S80 |
p. S99-S102
4 p.
|
artikel
|
| 13 |
Influence of target hemoglobin in dialysis patients on morbidity and mortality
|
Collins, Allan J.
|
|
2002
|
|
S80 |
p. S44-S48
5 p.
|
artikel
|
| 14 |
Introduction
|
Aljama, Pedro
|
|
2002
|
|
S80 |
p. S3-S4
2 p.
|
artikel
|
| 15 |
Kidney and hypertension
|
Adamczak, Marcin
|
|
2002
|
|
S80 |
p. S62-S67
6 p.
|
artikel
|
| 16 |
Measurement of renal function in pre-ESRD patients
|
Rodrigo, Emilio
|
|
2002
|
|
S80 |
p. S11-S17
7 p.
|
artikel
|
| 17 |
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?
|
Stenvinkel, Peter
|
|
2002
|
|
S80 |
p. S103-S108
6 p.
|
artikel
|
| 18 |
My dear Fernando
|
Cruz, Jose Miguel
|
|
2002
|
|
S80 |
p. S167-
1 p.
|
artikel
|
| 19 |
New approaches to delay the progression of chronic renal failure
|
Klahr, Saulo
|
|
2002
|
|
S80 |
p. S23-S26
4 p.
|
artikel
|
| 20 |
Occult infection of old nonfunctioning arteriovenous grafts: A novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients
|
Nassar, George M.
|
|
2002
|
|
S80 |
p. S49-S54
6 p.
|
artikel
|
| 21 |
Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?
|
Morena, Marion
|
|
2002
|
|
S80 |
p. S109-S114
6 p.
|
artikel
|
| 22 |
Parathyroidectomy in dialysis patients
|
De Francisco, Angel L.M.
|
|
2002
|
|
S80 |
p. S161-S166
6 p.
|
artikel
|
| 23 |
Pathogenesis of refractory secondary hyperparathyroidism
|
Rodriguez, Mariano
|
|
2002
|
|
S80 |
p. S155-S160
6 p.
|
artikel
|
| 24 |
Return to dialysis after renal transplantation. Which would be the best way?
|
Arias, Manuel
|
|
2002
|
|
S80 |
p. S85-S88
4 p.
|
artikel
|
| 25 |
Slowing the progression of renal failure
|
Praga, Manuel
|
|
2002
|
|
S80 |
p. S18-S22
5 p.
|
artikel
|
| 26 |
Strategies to decrease cardiovascular mortality in patients with end-stage renal disease
|
Dikow, Ralf
|
|
2002
|
|
S80 |
p. S5-S10
6 p.
|
artikel
|
| 27 |
The bioartificial kidney in the treatment of acute renal failure
|
Humes, H. David
|
|
2002
|
|
S80 |
p. S121-S125
5 p.
|
artikel
|
| 28 |
The calcimimetic agents: Perspectives for treatment
|
Frazão, João M.
|
|
2002
|
|
S80 |
p. S149-S154
6 p.
|
artikel
|
| 29 |
The importance of convective transport
|
Locatelli, Francesco
|
|
2002
|
|
S80 |
p. S115-S120
6 p.
|
artikel
|
| 30 |
What should the optimal target hemoglobin be? 1 1 This article is dedicated to the memory of Fernando Valderrábano, who, over the last decade, was involved in the study of renal anemia with the goal of achieving optimal care and improved quality of life for all patients with CKD.
|
Gómez, Juan M. López
|
|
2002
|
|
S80 |
p. S39-S43
5 p.
|
artikel
|
Tijdschrift beschrijving